Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Record of Investor Meetings – Mar’20 04th Jun 2020 Allotment of 31,762 equity shares under ESOS 01st Jun 2020 Schedule of Analyst and Institutional Investors meetings 27th May 2020 Schedule of Analyst / Institutional Investor meetings 22nd May 2020 Record of Investor Meetings – May’20 21st May 2020 Cipla Limited receives final approval for generic version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) with a Competitive Generic Therapy Designation 21st May 2020 Schedule of Analyst and Institutional Investors meetings 19th May 2020 Press Release – Cipla files ANDA for generic version of GSK’s Advair Diskus® 18th May 2020 Grant of ESOPs under Employee Stock Option Scheme 2013-A of the Company 16th May 2020 Outcome of the Board Meeting 15th May 2020 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
